Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is PTrana Meditama Metropolitan Tbk PEG Ratio?
PTrana Meditama Metropolitan TbkISX:SAME -0.65%79 PEG Ratio is 10.26 as of Jul. 17, 2026, which is 22% above its 10-year median of 8.40. GuruFocus rates ISX:SAME with a GF Score™ of 79/100 and a GF Value™ of Rp355.08 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 224 Healthcare Providers & Services companies, PTrana Meditama Metropolitan Tbk ranks worse than 90.63% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for PTrana Meditama Metropolitan Tbk's PEG Ratio or its related term are showing as below:
ISX:SAME'
s PEG Ratio Range Over the Past 10 Years
Min: 2.65 Med: 8.4 Max: 44.97
Current: 10.26
During the past 13 years, PTrana Meditama Metropolitan Tbk's highest PEG Ratio was 44.97. The lowest was 2.65. And the median was 8.40.
ISX:SAME's PEG Ratio is ranked worse than 90.63% of 224
companies
in the Healthcare Providers & Services industry
Industry Median: 1.415
vs ISX:SAME: 10.26
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
PTrana Meditama Metropolitan Tbk (ISX:SAME) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
PTrana Meditama Metropolitan Tbk PEG Ratio Related Terms
PTrana Meditama Metropolitan Tbk PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PTrana Meditama Metropolitan Tbk's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PTrana Meditama Metropolitan Tbk PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PTrana Meditama Metropolitan Tbk's PEG Ratio distribution charts can be found below:
* The bar in red indicates where PTrana Meditama Metropolitan Tbk's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a PEG Ratio of 10.26 as of Jul. 17, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on PTrana Meditama Metropolitan Tbk and its competitors. This is 22% above median its historical median of 8.40. Over the past decade, PTrana Meditama Metropolitan Tbk's PEG Ratio has ranged from 2.65 to 44.97. According to the industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #203 out of 224 companies in the Healthcare Providers & Services industry, placing it in the top 90.6%.
Is PTrana Meditama Metropolitan Tbk's PEG Ratio too high?
PTrana Meditama Metropolitan Tbk's current PEG Ratio of 10.26 is 22% above median its 10-year median of 8.40. Over the past 10 years, this metric has ranged from a low of 2.65 to a high of 44.97. The Healthcare Providers & Services industry median PEG Ratio is 1.42. PTrana Meditama Metropolitan Tbk's value of 10.26 is 625.1% above this industry median. Based on the distribution chart, PTrana Meditama Metropolitan Tbk ranks #203 out of 224 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's PEG Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #203 out of 224 companies for PEG Ratio. This places PTrana Meditama Metropolitan Tbk in the lower half of its industry. The industry median PEG Ratio is 1.42. PTrana Meditama Metropolitan Tbk's value of 10.26 is 625.1% above this benchmark. Historically, PTrana Meditama Metropolitan Tbk's own PEG Ratio has ranged from 2.65 to 44.97 over the past decade. While the company's 10-year median is 8.40 vs. the industry median of 1.42, PTrana Meditama Metropolitan Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.42, based on 224 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PTrana Meditama Metropolitan Tbk's current PEG Ratio of 10.26 is 625.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on PTrana Meditama Metropolitan Tbk and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PTrana Meditama Metropolitan Tbk's current PEG Ratio is 10.26, which is 22% above median its own 10-year median of 8.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp355.08, compared to a current price of Rp306.00 — trading 13.8% below its estimated fair value. The current PEG Ratio is 10.26, which is 22% above median its 10-year median of 8.40 and 625.1% above the Healthcare Providers & Services industry median of 1.42. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current PEG Ratio is 10.26 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued.
The current stock price of Rp306.00 is trading 13.8% below its estimated GF Value™ of Rp355.08.
GuruFocus considers PTrana Meditama Metropolitan Tbk to be Modestly Undervalued.
Key valuation signals for ISX:SAME:
PEG Ratio: 10.26 (22% above median its 10-year median of 8.40)
GF Value™: Rp355.08 vs. price of Rp306.00 (13.8% below fair value)
Industry Position: 625.1% above the Healthcare Providers & Services median (#203 of 224)
No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PTrana Meditama Metropolitan Tbk Business Description
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
79GF Score
Get the complete analysis for ISX:SAME
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SAME has been successfully added to your 
